輸入代號或公司名稱後按 Enter
6666

羅麗芬-KY

-0.85 (-1.90%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
44.0057成交張數12.90本益比1.15股價淨值比4.55%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q22.6390.6%3.411.2528.3%6.96%9.63%
2026Q10.32-44.8%2.160.156.6%0.86%5.84%
2025Q4-0.212.42-0.10-3.8%-0.59%6.79%
2025Q30.67-1.5%2.380.3212.3%2.00%6.78%
2025Q21.3842.3%2.390.6618.8%4.00%7.13%
2025Q10.5893.3%1.980.2711.0%1.60%5.55%
2024Q4-0.25-2600.0%1.70-0.12-4.8%-0.68%4.92%
2024Q30.6883.8%1.960.3210.7%1.91%5.55%
2024Q20.97-16.4%1.650.4613.2%2.80%4.87%
2024Q10.30-6.3%1.840.145.9%0.87%5.36%
2023Q40.011.860.000.2%0.03%5.51%
2023Q30.3760.9%1.380.187.6%1.09%3.98%
2023Q21.169.4%1.240.5517.8%3.47%3.67%
2023Q10.32-5.9%1.140.158.0%0.93%3.25%
2022Q4-0.47-188.7%1.16-0.22-11.9%-1.39%3.43%
2022Q30.231050.0%2.160.115.1%0.67%6.38%
2022Q21.0671.0%1.950.5018.1%3.04%5.64%
2022Q10.349.7%1.510.168.8%0.99%4.34%
2021Q40.53-61.0%1.480.259.8%1.58%4.34%
2021Q30.02-96.3%2.310.010.7%0.08%7.07%
2021Q20.6287.9%2.830.2910.3%1.77%8.48%
2021Q10.312.540.158.1%0.89%6.91%
2020Q41.36-52.6%2.200.6518.3%4.06%5.98%
2020Q30.54-73.7%3.710.2511.9%1.66%10.71%
2020Q20.33-89.7%5.220.169.5%0.95%15.60%
2020Q1-0.03-101.3%8.11-0.01-1.3%-0.08%20.96%
2019Q42.8710.501.3632.5%7.58%28.08%
2019Q32.050.9730.7%5.68%
2019Q23.221.5237.9%8.68%
2019Q12.361.1236.3%6.35%